Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best SS-LUP-332 Dosage for ERR Agonist: Comparison Across Study Models

Murine skeletal muscle biogenesis 20–25 mg/kg daily Mitochondrial DNA copy number, COX4/TFAM mRNA, VO2max 2 hours into dark phase Gold standard for endurance and mitochondrial density studies. Doses above 25 mg/kg show diminishing returns Hepatic metabolic dys

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Murine skeletal muscle biogenesis
  • 20–25 mg/kg daily
  • Mitochondrial DNA copy number, COX4/TFAM mRNA, VO2max
  • 2 hours into dark phase
  • Gold standard for endurance and mitochondrial density studies. Doses above 25 mg/kg show diminishing returns
  • Hepatic metabolic dysfunction (NAFLD models)
  • 15–20 mg/kg daily
  • Hepatic triglyceride content, β-oxidation enzyme expression, insulin sensitivity
  • Early dark phase or ZT13–15
  • Lower dose sufficient due to higher baseline ERRγ expression in liver tissue
  • Brown adipose thermogenesis
  • UCP1 protein expression, oxygen consumption in BAT, core body temperature
  • Mid-dark phase during peak metabolic activity
  • Requires upper dosing range. Adipose ERR receptor density is ~40% lower than muscle
  • Acute mitochondrial respiration (single-dose)
  • 30–40 mg/kg single administration
  • Real-time oxygen flux via Oroboros Oxygraph, complex I/II activity
  • 3 hours prior to tissue harvest
  • Higher single doses acceptable for acute mechanistic studies. Chronic use at this range triggers feedback inhibition